-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S7bbUKbCCq1AUPjwjK7wb5GY4ZUYUqgmXwBOoHUIfI4fJ6m/6r86qcklz6/En4kQ GxNWDdY94n7Yd3jRTXReVg== 0000014272-07-000167.txt : 20070802 0000014272-07-000167.hdr.sgml : 20070802 20070802152556 ACCESSION NUMBER: 0000014272-07-000167 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070524 FILED AS OF DATE: 20070802 DATE AS OF CHANGE: 20070802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOOPER ANTHONY C CENTRAL INDEX KEY: 0001277244 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 071020253 BUSINESS ADDRESS: STREET 1: BRISTOL MYERS SQUIBB CO STREET 2: RT 206 & PROVINCE LINE RD CITY: PRINCETON STATE: NJ ZIP: 08543 BUSINESS PHONE: 6098583952 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 3/A 1 hoo747.xml X0202 3/A 2007-05-24 2007-06-01 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001277244 HOOPER ANTHONY C BRISTOL-MYERS SQUIBB COMPANY RT. 206 & PROVINCELINE ROAD PRINCETON NJ 08540 0 1 0 0 President US Pharmaceuticals Common Stock, $0.10 par value 110088 D Common Stock, $0.10 par value 2784.97 I By BMY Savings & Investment Program Common Stock, $0.10 par value 3675 I By Spouse Executive Option (right to buy) 62.95 2000-01-04 2009-01-03 Common Stock, $0.10 par value 30813.00 D Executive Option (right to buy) 59.78 2002-03-06 2011-03-05 Common Stock, $0.10 par value 36150.00 D Executive Option (right to buy) 25.45 2015-02-28 Common Stock, $0.10 par value 55833.00 D Executive Option (right to buy) 22.73 2016-03-06 Common Stock, $0.10 par value 78750.00 D Executive Option (right to buy) 24.74 2016-11-30 Common Stock, $0.10 par value 200000.00 D Executive Option (right to buy) 27.01 2017-03-05 Common Stock, $0.10 par value 104616.00 D Option (right to buy) 48.45 1999-03-03 2008-03-02 Common Stock, $0.10 par value 25660.00 D Option (right to buy) 61.09 2001-01-03 2010-01-02 Common Stock, $0.10 par value 2524.00 D Option (right to buy) 42.64 2001-03-07 2010-03-06 Common Stock, $0.10 par value 33127.00 D Option (right to buy) 48.08 2003-03-05 2012-03-04 Common Stock, $0.10 par value 40000.00 D Option (right to buy) 28.90 2005-06-04 2007-06-03 Common Stock, $0.10 par value 30000.00 D Option (right to buy) 23.14 2004-03-04 2013-03-03 Common Stock, $0.10 par value 68000.00 D Option (right to buy) 28.11 2014-03-01 Common Stock, $0.10 par value 63333.00 D Restricted Stock Units Common Stock, $0.10 par value 26151.00 D This Form 3 is being amended to correct the number of shares directly held. The total includes 83,578 shares of unvested restricted stock. Based on a plan statement as of the end of the most recent fiscal quarter. Currently Exercisable. 18,075 shares are currently exercisable. The remaining 18,075 shares are exercisable on the earlier to occur of (i) the closing share price achieving a price threshold and remaining at that threshold for a given number of days or (ii) March 6, 2009. 27,916 shares are currently exercisable. An additional 13,958 shares will become exercisable on each of March 1, 2008 and March 1, 2009. 19,687 shares are currently exercisable. The remaining shares will vest 25% on each of March 7, 2008, March 7, 2009 and March 7, 2010. One-third of the options will become exercisable on each of December 1, 2009, December 1, 2010 and December 1, 2011. Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. 25% of the shares vest annually, on a cumulative basis, on March 6, 2008, March 6, 2009, March 6, 2010 and Mach 6, 2011. 47,499 shares are currently exercisable and the remaining 15,834 shares will beome exercisable on March 2, 2008. One-third of the restricted stock units will vest on each of March 6, 2010, March 6, 2011 and March 6, 2012 and will be converted into shares of common stock. Each restricted stock unit converts into one share of common stock upon vesting. By: /s/ Sonia Vora, Attorney-in-Fact 2007-08-02 -----END PRIVACY-ENHANCED MESSAGE-----